US BANCORP \DE\ - THERAPEUTICSMD INC ownership

THERAPEUTICSMD INC's ticker is and the CUSIP is 88338N206. A total of 44 filers reported holding THERAPEUTICSMD INC in Q1 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of THERAPEUTICSMD INC
ValueSharesWeighting
Q3 2023$743
-26.7%
2460.0%0.00%
Q2 2023$1,014
+9.9%
2460.0%0.00%
Q1 2023$923
-32.9%
2460.0%0.00%
Q4 2022$1,375
-31.2%
2460.0%0.00%
Q3 2022$2,0000.0%2460.0%0.00%
Q2 2022$2,0002460.00%
Other shareholders
THERAPEUTICSMD INC shareholders Q1 2023
NameSharesValueWeighting ↓
Tejara Capital Ltd 355,679$1,333,7960.68%
Clearline Capital LP 419,425$1,572,8440.24%
Rubric Capital Management LP 1,192,191$4,470,7160.12%
Sixth Street Partners Management Company, L.P. 124,659$467,4710.05%
SANDERS MORRIS HARRIS LLC 33,577$125,9140.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 42,000$157,5000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 38,042$142,6580.00%
J. Goldman & Co LP 13,562$50,8580.00%
GABELLI FUNDS LLC 31,000$116,2500.00%
OSAIC HOLDINGS, INC. 517$1,9370.00%
View complete list of THERAPEUTICSMD INC shareholders